Business
Pre Close Trading Update
Pre Close Trading Update.
About this update from Genedrive Plc
[{"type":"text","content":"\n \nRNS Number : 9235M Epistem Holdings plc 22 July 2014 \n \n\nCompany Epistem Plc\nTIDM EHP.L (AIM)\nHeadline Pre-Close Trading Update \nReleased 22nd July: 7.00am UK\n \nEpistem Holdings Plc\n(\"Epistem\" or \"the Company\")\nPre-Close Trading Update \nEpistem (AIM: EHP), the personalised medicine and biotechnology company, today announces a pre-close trading statement for the year ended 30th June 2014.\nIncome over the full year remained solid and broadly in line with market expectations, with EBITDA losses expected to be around £2.5m reflecting the growing expenditure in preparation for launch of the Company's first product Genedrive®. Net cash at 30th June 2014 was £4.2m.\nThe Company expects to release its final results for the year ended 30th June 2014 on Tuesday 28th October 2014 and will hold an analysts' meeting on the day. \n \nFor further information contact:\nEpistem Plc\nMatthew Walls, Chief Executive Officer ++44 161 606 7258 John Rylands, Chief Financial Officer\n \nPeel Hunt LLP\nJames Steel ++44 207 418 8900 \nClare Terlouw\n &...